| Publications
·
Hara-Chikuma
M, Wang Y, Guggino SE, Guggino WB, & Verkman AS (2005).
Impaired acidification in early endosomes of ClC-5 deficient
proximal tubule. Biochem Biophys Res Commun 329,
941-946.
·
Lewis
HA, Zhao X, Wang C, Sauder JM, Rooney I, Noland BW, Lorimer D,
Kearins MC, Conners K, Condon B, Maloney PC, Guggino WB,
Hunt JF, & Emtage S (2005). Impact of the DeltaF508 Mutation in
First Nucleotide-binding Domain of Human Cystic Fibrosis
Transmembrane Conductance Regulator on Domain Folding and
Structure. J Biol Chem 280, 1346-1353.
·
Li Y,
Wright JM, Qian F, Germino GG, & Guggino WB (2005).
Polycystin 2 interacts with type I inositol 1,4,5-trisphosphate
receptor to modulate intracellular Ca2+ signaling. J Biol
Chem 280, 41298-41306.
·
Rebelo
MA, Tostes V, Araujo NC, Martini SV, Botelho BF, Guggino WB,
& Morales MM (2005). Screening for CLCN5 mutation in renal
calcium stone formers patients. An Acad Bras Cienc 77,
95-101.
·
Wang Y,
Cai H, Cebotaru L, Hryciw DH, Weinman EJ, Donowitz M, Guggino
SE, & Guggino WB (2005). ClC-5: role in endocytosis in
the proximal tubule. Am J Physiol Renal Physiol. 289,
F850-F862.
·
Cheng
J, Wang H, & Guggino WB (2004). Modulation of mature
cystic fibrosis transmembrane regulator protein by the PDZ
domain protein CAL. J Biol Chem 279, 1892-1898.
·
Chikhlikar P, Barros de AL, Agrawal S, Byrne B, Guggino W,
August JT, & Marques ET, Jr. (2004). Inverted terminal repeat
sequences of adeno-associated virus enhance the antibody and
CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera.
Virology 323, 220-232.
·
Guggino WB
& Banks-Schlegel SP (2004). Macromolecular interactions and ion
transport in cystic fibrosis. Am J Respir Crit Care Med
170, 815-820.
·
Guggino WB
(2004). The cystic fibrosis transmembrane regulator forms
macromolecular complexes with PDZ domain scaffold proteins.
Proc Am Thorac Soc 1, 28-32.
·
Hryciw
DH, Ekberg J, Lee A, Lensink IL, Kumar S, Guggino WB,
Cook DI, Pollock CA, & Poronnik P (2004). Nedd4-2 functionally
interacts with ClC-5: involvement in constitutive albumin
endocytosis in proximal tubule cells. J Biol Chem.279,
54996-55007.
·
Karp
CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R, Yang R,
Uddin J, Guggino WB, Atabani SF, Belkaid Y, Xu Y,
Whitsett JA, Accurso FJ, Wills-Karp M, & Petasis NA (2004).
Defective lipoxin-mediated anti-inflammatory activity in the
cystic fibrosis airway. Nat Immunol 5, 388-392.
·
Kwon SH
& Guggino WB (2004). Multiple sequences in the C terminus
of MaxiK channels are involved in expression, movement to the
cell surface, and apical localization. Proc Natl Acad Sci U S
A. 101, 15237-15242.
·
Lewis
HA, Buchanan SG, Burley SK, Conners K, Dickey M, Dorwart M,
Fowler R, Gao X, Guggino WB, Hendrickson WA, Hunt JF,
Kearins MC, Lorimer D, Maloney PC, Post KW, Rajashankar KR,
Rutter ME, Sauder JM, Shriver S, Thibodeau PH, Thomas PJ, Zhang
M, Zhao X, & Emtage S (2004). Structure of nucleotide-binding
domain 1 of the cystic fibrosis transmembrane conductance
regulator. EMBO J 23, 282-293.
·
Sirninger J, Muller C, Braag S, Tang Q, Yue H, Detrisac C,
Ferkol T, Guggino WB, & Flotte TR (2004). Functional
characterization of a recombinant adeno-associated virus
5-pseudotyped cystic fibrosis transmembrane conductance
regulator vector. Hum Gene Ther 15, 832-841.
·
Wright
JM, Zeitlin PL, Cebotaru L, Guggino SE, & Guggino WB
(2004). Gene expression profile analysis of 4-phenylbutyrate
treatment of IB3-1 bronchial epithelial cell line demonstrates a
major influence on heat-shock proteins. Physiol Genomics
16, 204-211.
·
Zeitlin
PL, Boyle MP, Guggino WB, & Molina L (2004). A phase I
trial of intranasal Moli1901 for cystic fibrosis. Chest
125, 143-149.
·
Boyle
MP, Enke RA, Mogayzel PJ, Jr., Guggino WB, Martin DB,
Agarwal S, & Zeitlin PL (2003). Effect of adeno-associated
virus-specific immunoglobulin G in human amniotic fluid on gene
transfer. Hum Gene Ther 14, 365-373.
·
Christensen EI, Devuyst O, Dom G, Nielsen R, Van der SP,
Verroust P, Leruth M, Guggino WB, & Courtoy PJ (2003).
Loss of chloride channel ClC-5 impairs endocytosis by defective
trafficking of megalin and cubilin in kidney proximal tubules.
Proc Natl Acad Sci U S A 100, 8472-8477.
·
Fischer
AC, Beck SE, Smith CI, Laube BL, Askin FB, Guggino SE, Adams RJ,
Flotte TR, & Guggino WB (2003). Successful transgene
expression with serial doses of aerosolized rAAV2 vectors in
rhesus macaques. Mol Ther 8, 918-926.
·
Flotte
TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S,
Conrad CK, Brass-Ernst L, Humphries M, Sullivan K, Wetzel R,
Taylor G, Carter BJ, & Guggino WB (2003). Phase I trial
of intranasal and endobronchial administration of a recombinant
adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult
cystic fibrosis patients: a two-part clinical study. Hum Gene
Ther 14, 1079-1088.
·
Fong P,
Argent BE, Guggino WB, & Gray MA (2003). Characterization
of vectorial chloride transport pathways in the human pancreatic
duct adenocarcinoma cell line HPAF. Am J Physiol Cell Physiol
285, C433-C445.
·
Hryciw
DH, Wang Y, Devuyst O, Pollock CA, Poronnik P, & Guggino WB
(2003). Cofilin interacts with ClC-5 and regulates albumin
uptake in proximal tubule cell lines. J Biol Chem 278,
40169-40176.
·
Nascimento DS, Reis CU, Goldenberg RC, Ortiga-Carvalho TM,
Pazos-Moura CC, Guggino SE, Guggino WB, & Morales MM
(2003). Estrogen modulates ClC-2 chloride channel gene
expression in rat kidney. Pflugers Arch 446,
593-599.
·
Santos
OD, Grozovsky R, Goldenberg RC, Carvalho DP, Fong P, Guggino
WB, & Morales M (2003). Thyroid hormone modulates ClC-2
chloride channel gene expression in rat renal proximal tubules.
J Endocrinol 178, 503-511.
·
Silva
IV, Cebotaru V, Wang H, Wang XT, Wang SS, Guo G, Devuyst O,
Thakker RV, Guggino WB, & Guggino SE (2003). The ClC-5
knockout mouse model of Dent's disease has renal hypercalciuria
and increased bone turnover. J Bone Miner Res 18,
615-623.
1 2 3
4 5
6 7
8 9
10
11 |